A recovery for both OPTI:Optibiotix and JLP:Jubilee Metals saw the deficit between cost and value reduce by £7,178 to £126,210, and deficit between injection amount and value reduced to £56,692. Total portfolio value went back above £100k to £106,570.
ASHM:Ashmore Group had a dreadful week, losing 17%, so they are now 36% down.
CWR:Ceres Power also did really badly, dropping 14% to go 22% down after only recently being in profit.
SBTX:SkinBioTherapeutics have been pretty volatile and dropped 12% this week.
PSN:Persimmon dropped 10% to go from break-even to a 10% loss.
PBX:Probiotix Health fell 8% as the good news in recent results has now been forgotten.
CAML:Central
Asia Metals inexplicably dropped 6% and despite being a massively profitable copper company are losing me lots of money.
SAE:Simec Atlantis Energy fell 6% and are now 80% down.
III:3i Group fought back against the shorters and gained 5% to go 108% up. A cynic would say the so-called shorting attack was just a ruse to try and get some cheaper shares.
FOUR:4imprint went up 8% and are now 3% in profit.
FXPO:Ferrexpo climbed 17% as people mistakenly think Trump can end the war. They are still 84% down and I don't have much hope in ever breaking even on them.
JLP:Jubilee Metals may have finally finished being sold by the big fund that's closing, as they went up 17% after a protracted and relentless fall. Some of my holdings are even in profit.
AFC:AFC Energy went up 20% for no obvious reason, but are still 45% down
Share of the Week is OPTI:Optibiotix, which went up 23% but I don't know why.
Here's the ISA and shares portfolio after week 15 of year 10.
Weekly Change | |||
Cash | £6.90 | +£0 | |
Portfolio cost | £111,553.84 | +£0 | |
Portfolio sell value (bid price-commission) |
£43,600.74 | (-60.9%) | +£4,095.73 |
Potential profits | £0 | +£0 | |
Yr 10 Dividends | £53.50 | +£0 | |
Yr 10 Interest | £0.37 | +£0 | |
Yr 10 Profit from sales | £243.66 | +£0 | |
Yr 10 proj avg monthly profit | £78.70 | (1.2%) | -£5.62 |
Total Dividends | £12,275.99 | +£0 | |
Total Interest | £7.17 | +£0 | |
Total Profit from sales | £18,121.50 | +£0 | |
Average monthly cash profit | £268.36 | (3.9%) | -£0.56 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Compound performance | 36% | +0% |
Big increase thanks to OPTI:Optibiotix and JLP:Jubileee Metals.
Tiny tick up
Still below the trend line
The SIPP looks like this after week 467 overall and week 51 of year 9.
Weekly Change | ||||
Cash | £89.98 | -£170.42 |
||
Portfolio cost | £118,993.69 | +£750.31 | ||
Portfolio sell value (bid price - commission) |
£61,558.52 | (-48.3%) | +£3,003.40 | |
Potential profits | £5,551.20 | +£445.25 | ||
Yr 9 Dividends | £1,481.77 | +£14.00 | ||
Yr 9 Interest | £6.45 | +£0 | ||
Yr 9 Profit from sales | £6,172.04 | +£565.89 | ||
Yr 9 proj avg monthly profit | £633.27 | (9.7%) | +£37.59 | |
Total Dividends | £16,116.65 | +£14.00 | ||
Total Interest | £12.38 | +£0 | ||
Total Profit from sales | £17,007.94 | +£565.89 | ||
Average monthly cash profit | £294.82 | (4.5%) | +£4.76 | |
(Sold stocks profit + Dividends - Fees / Months) |
||||
Compound performance | 40% | +0% |
Just as I was about to go on holiday I decided to sell the JLP:Jubilee Metals shares I had bought after selling most of my CAML:Central Asia Metals holding. I sold 82,361 shares for 5.2401p making £565.89 (15%) profit. I bought back 2,640 CAML:Central Asia Metals shares for 169.5576p costing £4,488.27. That's 580 more than I originally sold, so I've increased my holding by 28% as a result of lending the cash to JLP. That doesn't usually work for me, so it makes a nice change.
I got a £14 dividend from PSN:Persimmon, and potential profits rose by £445 despite cashing in £565 from the sale.
Still a disappointingly small tick up.
So nearly crossing the trend line.
The trading account looks like this after week 433 overall and week 17 of year 9.
The rise in JLP:Jubilee Metals caused value to go up by £79, but the crash in SBTX:SkinBioTherapeutics wiped out all potential profits.
A more encouraging slope upwards.
Another one eager to cross the trend line.
Still a disappointingly small tick up.
So nearly crossing the trend line.
The trading account looks like this after week 433 overall and week 17 of year 9.
Weekly Change | |||
Cash | £63.39 | +£0 | |
Portfolio cost | £2,073.87 | +£0 | |
Portfolio sell value (bid price - commission) | £1,251.19 | (-39.7%) | +£79.56 |
Potential profits | £0 | -£31.81 | |
Year 9 Dividends | £0 | +£0 | |
Year 9 Interest | £0 | +£0 | |
Year 9 Profit | £0 | +£0 | |
Yr 8 proj avg monthly profit | £0 | (+0%) | +£0 |
Dividends | £85.46 | +£0 | |
Interest | £0.03 | +£0 | |
Profit from sales | -£602.54 | +£0 | |
Average monthly cash profit | -£5.17 | (-3.0%) | +£0.02 |
(Sold stocks profit + Dividends - Fees / Months) |
The rise in JLP:Jubilee Metals caused value to go up by £79, but the crash in SBTX:SkinBioTherapeutics wiped out all potential profits.
A more encouraging slope upwards.
Another one eager to cross the trend line.
That's it for Week 483. Lots of holiday entries to catch up on, as I was able to take weekly snapshots so can write them all up now I'm back.
No comments:
Post a Comment